Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-25 @ 8:41 PM
Study NCT ID:
NCT04251169
Status:
TERMINATED
Last Update Posted:
2025-06-03
First Post:
2020-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression
Sponsor:
SOLTI Breast Cancer Research Group